Adrenergics Flashcards
A group of non-selective agents grouped according to mode of action. Directly interacts with and activates on one or more of the adrenoreceptors;
Direct Acting Agents
Endogenous drug mainly used for anaphylactic shock + bronchodilator.
Epinephrine
Give the 4 catecholamines and classify them as endogenous and exogenous.
Endo - Epi, Norepi, Dop; Exo: Isoproterenol
Selective a1 agonist that is used as oral/nasal decongestant, vasopressor, mydriatic and hemostatic agent.
Phenylephrine
SHORT ACTING Selective B2 agonist used for asthma/COPD
Salbutamol, Albuterol, Terbutaline
Selective B3 agonist used for overreactive bladder
Mirabegron
Agents that depend on the ability to increase the endogenous catcholamines endings to stimulate adrenergic receptor by 2 mechanisms: release/displace stored NE from adrenergic receptors or decrease clearance of released NE.
Indirect Acting Agents
Drug that displace/release stored NE from adrenergic nerve endings. Used for ADHD and narcolepsy, off-label indicated for obesity.
Amphetamine
Drug that displace/release stored NE from adrenergic nerve endings. Still used for ADHD and narcolepsy
Methylphenidate
Indirect-acting drugs withdrawn due to hepatic failure. Drug that displace/release stored NE from adrenergic nerve endings
Pemoline
Indirect-acting drug that displace/release stored NE from adrenergic nerve endings for narcolepsy.
Modafinil
Indirect-acting substance that displace/release stored NE from adrenergic nerve endings (NOT a drug) and found from aged cheese, anchovies, pickled herring
Tryamine
Indirect-acting drug that decrease clearance of released norepinephrine (catecholamine reuptake inhibitors) w/c function for serotonin and dopamine release. Also to manage bed-wetting problems.
Tricyclic antidepressants
Indirect-acting drug that decrease clearance of released norepinephrine (catecholamine reuptake inhibitors) w/c treats ADHD.
Atomexotine, Reboxetine
Indirect-acting drug that decrease clearance of released norepinephrine (catecholamine reuptake inhibitors) that functions as antidepressants and for fibromyalgia.
Duloxetine
Indirect-acting drug that decrease clearance of released norepinephrine (catecholamine reuptake inhibitors) which treats fibromyalgia.
Milnacipran
Indirect-acting drugs that block metabolizing enzymes (decrease clearance of NE) which function as MOA inhibitor
Pargyline
Indirect-acting drugs that block metabolizing enzymes (decrease clearance of NE) which function as COMT inhibitor.
Entacapone
Which group of drugs ndirectly release NE and also directly activate receptors
Mixed-acting sympathomimetics
A mixed acting drug which can activate both a and b receptors used for oral/nasal decongestant. Indirectly releases NE. Can also traverse BBB.
Ephedrine
A mixed acting drug which is also an oral/nasal decongestant BUT is now REGULATED due to shabu use.
Pseudoephedrine
A mixed acting drug which can be an oral/nasal decongestant and for weight loss in high doses BUT can cause hemorrhagic stroke.
Phenylpropanolamine (Regulated dose: 12.5-30 mg)
A mixed acting drug which can prevent hypotension after administering spinal anesthesia.
Mephentermine
A mixed acting drug which are for hypotensive states.
Metaraminol
Drug most potent in B receptor activation.
Isoproterenol / Isoprenaline
Non selective receptor agonists. Epinephrine actiaves ____ and norepinephrine activates ____.
all; a and b1
Selective a1 agonist treatment for orthostatic hypotension.
Midodrine
Selective a1 agonist. Imidazole-derived short-acting topical nasal decongestants
Naphazoline, Tetrahydrozoline
Selective a1 agonist. Imidazole-derived long-acting topical nasal decongestants
Oxymetazoline, Xylometazoline
Selective/centrally acting a2 agonist for wide-angle glaucoma.
Apraclonidine, Brimonidine
Centrally acting a2 agonists (4 drugs)
Clonidine, Methyldopa, Guanfacine, Guanabenz
Selective/centrally acting a2 agonist for muscle spasticity and spinal cord disorders.
Tizanidine
Selective B1 agonist but can also activate a receptors.
Dobutamine
Partial B1 agonist.
Pranelterol